An Endocytic Pathway Essential for Renal Uptake and Activation of the Steroid 25-(OH) Vitamin D3
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bikle, 1985, Serum protein binding of 1, 25-dihydroxyvitamin D, J. Clin. Endocrinol. Metab., 61, 969, 10.1210/jcem-61-5-969
Bikle, 1986, Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein, J. Clin. Endocrinol. Metab., 63, 954, 10.1210/jcem-63-4-954
Christensen, 1995, Segmental distribution of the endocytosis receptor gp330 in renal proximal tubules, Eur. J. Cell. Biol., 66, 349
Cooke, N.E., Safadi, F.F., Magiera, H.M., Thornton, P., Hollis, B., Liebhaber, S.A., Gentile, M., and Haddad, J.G. (1997). Biological consequence of vitamin D binding protein deficiency in a mouse model. In Vitamin D, A.W. Norman, R. Bouillon, and M. Thomasset, eds. (Riverside, CA: Vitamin D Workshop, Inc., University of CA), pp. 105–111.
Haddad, 1995, Plasma vitamin D-binding protein (Gc-globulin), J. Steroid Biochem. Mol. Biol., 53, 1, 10.1016/0960-0760(95)00104-8
Haddad, 1981, Vitamin D plasma binding protein. Turnover and fate in the rabbit, J. Clin. Invest., 67, 1550, 10.1172/JCI110186
Keenan, 1991, The uptake and metabolism of 25-hydroxyvitamin D3 and vitamin D binding protein by cultured porcine kidney cells, Int. J. Biochem., 23, 1225, 10.1016/0020-711X(91)90220-H
Moestrup, 1995, Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs, J. Clin. Invest., 96, 1404, 10.1172/JCI118176
Moestrup, 1996, Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin B12 homeostasis, Proc. Natl. Acad. Sci. USA, 93, 8612, 10.1073/pnas.93.16.8612
Moestrup, 1998, β2-glycoprotein-I (apolipoprotein H) and β2-glycoprotein-I-phospholipid complex harbor recognition site for the endocytic receptor megalin, J. Clin. Invest., 102, 902, 10.1172/JCI3772
Omdahl, 1980, In vitro regulation of kidney 25-hydroxyvitamin D3-hydroxylase enzyme activities by vitamin D3 metabolites, J. Biol. Chem., 255, 7460, 10.1016/S0021-9258(20)79726-7
Porto, 1991, Receptor-mediated endocytosis of an extracellular steroid-binding protein (TeBG) in MCF-7 human breast cancer cells, Endocrinology, 129, 436, 10.1210/endo-129-1-436
Porto, 1995, Receptors for androgen-binding proteins, J. Steroid Biochem. Mol. Biol., 53, 1, 10.1016/0960-0760(95)00111-C
Saito, 1994, Complete cloning and sequencing of rat gp330/“megalin.” A distinctive member of the low density lipoprotein receptor gene family, Proc. Natl. Acad. Sci. USA, 91, 9725, 10.1073/pnas.91.21.9725
Stefansson, 1995, gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex, J. Cell. Sci., 108, 2361, 10.1242/jcs.108.6.2361
Siiteri, 1986, Changing concepts of active androgens in blood, Clin. Endocrinol. Metab., 15, 247, 10.1016/S0300-595X(86)80023-8
Siiteri, 1982, The serum transport of steroid hormones, Recent Prog. Horm. Res., 38, 457
St. John, 1992, Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure, Nephron, 61, 422, 10.1159/000186960
Takeyama, 1997, 25-hydroxyvitamin D3 1 alpha-hydroxylase and vitamin D synthesis, Science, 277, 1827, 10.1126/science.277.5333.1827
Teranishi, 1983, Demonstration of vitamin D-binding protein in the urine of Itai-Itai disease patients, Toxicol. Lett., 15, 7, 10.1016/0378-4274(83)90161-3
Willnow, 1992, Low density lipoprotein receptor-related protein (LRP) and gp330 bind similar ligands, including plasminogen activator/inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance, J. Biol. Chem., 267, 26172, 10.1016/S0021-9258(18)35732-6
Willnow, 1996, Defective forebrain development in mice lacking gp330/megalin, Proc. Natl. Acad. Sci. USA, 93, 8460, 10.1073/pnas.93.16.8460